Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,258
Closed -$347K 430
2024
Q3
$347K Buy
4,258
+93
+2% +$7.44K 0.06% 280
2024
Q2
$309K Sell
4,165
-194
-4% -$14.5K 0.06% 271
2024
Q1
$340K Sell
4,359
-19
-0.4% -$1.41K 0.06% 255
2023
Q4
$313K Buy
4,378
+16
+0.4% +$1.11K 0.06% 260
2023
Q3
$302K Sell
4,362
-163
-4% -$12.3K 0.06% 247
2023
Q2
$366K Buy
+4,525
New +$370K 0.07% 232

Other funds holding HOLX

Portside Wealth Group's HOLX Position: Q4 2024 in Review

Portside Wealth Group sold out of Hologic (HOLX) in Q4 2024, closing a stake of 4,258 shares — an estimated $347K sold.

Portside Wealth Group first reported a position in HOLX in Q2 2023 and held it in 6 quarters. The position peaked at $366K in Q2 2023. 719 funds tracked by Wall St. Rank hold HOLX as of Q4 2024.

  • Portside Wealth Group reported no remaining Hologic position as of Q4 2024 after selling out during the quarter.
  • Portside Wealth Group sold 4,258 Hologic shares in Q4 2024, an estimated $347K.
  • Portside Wealth Group first reported a position in Hologic in Q2 2023 and held it in 6 quarters.
  • Portside Wealth Group's Hologic position peaked at $366K in Q2 2023.
  • 719 funds tracked by Wall St. Rank held Hologic as of Q4 2024.

Based on Portside Wealth Group's 13F filing for Q4 2024, filed 15 Jan 2025.